Name: ____________________________ Date: _______________
Endogenous opioid peptides, receptor subtypes, pain pathways, agonist classifications, structural families, allergy, histamine release, and potency.
Learning objectives
- Identify endogenous opioid peptides and major opioid receptor subtypes.
- Explain how opioids modify ascending and descending pain pathways.
- Differentiate full agonists, partial agonists, mixed agents, and antagonists.
- Separate true allergy from predictable effects and histamine-mediated reactions.
Complete the blanks as you watch. Use the time ranges to pause, review and discuss the key ideas with your faculty.
00:00 to 25:00
Reversal Context and Opioid History
- Reversal drugs may have a shorter duration than the drug being reversed, creating a risk of ________________.
- Opioids were used clinically long before their ________________s and endogenous ligands were identified.
- Discovery of opioid ________________s led to identification of endogenous peptides.
- Endogenous ________________ systems participate in pain modulation, stress, reward, and other functions.
25:00 to 45:00
Endogenous Peptides and Receptors
- Major endogenous opioid peptide families include endorphins, enkephalins, and ________________.
- The major ________________ families are mu, kappa, and delta.
- Mu receptor activation contributes strongly to analgesia, euphoria, ________________, and physical dependence.
- ________________ effects vary with subtype, anatomic location, dose, and drug selectivity.
30:00 to 50:00
Pain Pathways
- ________________ signals enter the spinal cord through primary afferent neurons and ascend toward the brain.
- ________________s reduce transmitter release presynaptically and hyperpolarize neurons postsynaptically.
- Descending pathways from the brainstem can ________________ spinal pain transmission.
- ________________ changes pain processing but does not necessarily eliminate the noxious stimulus.
50:00 to 72:00
Agonists Antagonists and Families
- A full agonist has high efficacy at its target opioid ________________.
- A partial agonist has lower ________________ and may limit the response compared with a full agonist.
- A pure antagonist blocks opioid ________________s without providing agonist analgesia.
- Structural families help anticipate ________________ but do not perfectly predict allergy.
72:00 to 87:48
Allergy Histamine and Potency
- Morphine and some related drugs can release ________________, causing flushing, itching, or hypotension.
- ________________ release is not automatically an IgE-mediated allergy.
- Potency compares the dose required for a given effect; it does not by itself determine safety or ________________.
- Equianalgesic comparison must account for route, incomplete cross-________________, and patient variability.
Notes & questions for class
Lecture recorded in 2017. Use current local protocols and faculty guidance for clinical decisions.